Digital Science is delighted to announce the launch of AI-driven summarization in Dimensions, a new feature to support the user in their discovery process for publications, grants, patents and clinical trials.
Tag: Generative AI
Working Towards Toxic-Free AI
Unlike existing work, which relies on training data from social media examples, a new benchmark, named ToxicChat, is based on examples gathered from real-world interactions between users and an AI-powered chatbot. ToxicChat is able to weed out queries that use seemingly harmless language but are actually harmful, which would pass muster with most current models.
Dimensions Research GPT – evidence-based research insights for ChatGPT platform users
Digital Science announces two new products – Dimensions Research GPT and Dimensions Research GPT Enterprise – bringing the unmatched, trusted research coverage of Dimensions to the ChatGPT platform.
Review reveals potential uses and pitfalls for generative AI in the medical setting
A narrative review from authors at Stanford University provides important insights for clinicians considering using large language models (LLMs) like ChatGPT in their routine practice, including suggestions for usage and potential pitfalls with mitigation strategies.
21st century Clippy: Cornell expert on conversational chatbots
People can now talk to and have a conversation with OpenAI’s chatbot ChatGPT. The company says it can generate human-like audio from just text and a few seconds of sample speech. Mor Naaman, professor at Cornell Tech, studies AI-mediated communication…
JBC editors weigh in on AI in science publishing
In an editorial, JBC says they’ll allow generative AI use in manuscript preparation but not during the review process.
AI makes it harder to spot deep fakes than ever before, but awareness is key, says expert
As artificial intelligence programs continue to develop and access is easier than ever, it’s making it harder to separate fact from fiction. Just this week, an AI-generated image of an explosion near the Pentagon made headlines online and even slightly impacted the stock market until it was quickly deemed a hoax.
MD Anderson and Generate:Biomedicines enter co-development and commercialization agreement to accelerate novel protein therapeutics for oncology using generative AI
MD Anderson and Generate:Biomedicines announced a co-development and commercialization agreement to accelerate novel protein therapies using generative AI.